Caseware UK (AP4) 2023.0.135 2023.0.135 2024-07-312024-07-31truefalseDormant2023-08-013truetrue 04226835 2023-08-01 2024-07-31 04226835 2022-08-01 2023-07-31 04226835 2024-07-31 04226835 2023-07-31 04226835 c:Director1 2023-08-01 2024-07-31 04226835 d:CurrentFinancialInstruments 2024-07-31 04226835 d:CurrentFinancialInstruments 2023-07-31 04226835 d:CurrentFinancialInstruments d:WithinOneYear 2024-07-31 04226835 d:CurrentFinancialInstruments d:WithinOneYear 2023-07-31 04226835 d:RetainedEarningsAccumulatedLosses 2024-07-31 04226835 d:RetainedEarningsAccumulatedLosses 2023-07-31 04226835 c:EntityNoLongerTradingButTradedInPast 2023-08-01 2024-07-31 04226835 c:FRS102 2023-08-01 2024-07-31 04226835 c:AuditExempt-NoAccountantsReport 2023-08-01 2024-07-31 04226835 c:AbridgedAccounts 2023-08-01 2024-07-31 04226835 c:CompanyLimitedByGuarantee 2023-08-01 2024-07-31 04226835 e:PoundSterling 2023-08-01 2024-07-31 iso4217:GBP xbrli:pure

Registered number: 04226835









CNM THE COLLEGE OF NATUROPATHIC & COMPLEMENTARY MEDICINE LTD
(A company limited by guarantee)








FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2024


 
CNM THE COLLEGE OF NATUROPATHIC & COMPLEMENTARY MEDICINE LTD
  
(A company limited by guarantee)
REGISTERED NUMBER:04226835

BALANCE SHEET
AS AT 31 JULY 2024

2024
2023
Note
£
£

  

Current assets
  

Debtors
  
-
166,848

Cash at bank and in hand
 4 
14,902
88,069

  
14,902
254,917

Creditors: amounts falling due within one year
 5 
(14,902)
-

Net current assets
  
 
 
-
 
 
254,917

Total assets less current liabilities
  
-
254,917

Net assets
  
-
254,917


Capital and reserves
  

Profit and loss account
  
-
254,917

Shareholders' funds
  
-
254,917


Page 1


 
CNM THE COLLEGE OF NATUROPATHIC & COMPLEMENTARY MEDICINE LTD
  
(A company limited by guarantee)
REGISTERED NUMBER:04226835
    
BALANCE SHEET (CONTINUED)
AS AT 31 JULY 2024

For the year ended 31 July 2024 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 1 October 2024.




................................................
Gunilla Gerber
Director

The notes on pages 3 to 4 form part of these financial statements.

Page 2


 
CNM THE COLLEGE OF NATUROPATHIC & COMPLEMENTARY MEDICINE LTD
 
(A company limited by guarantee)
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

1.


General information

The Company is incorporated in England and Wales and is limited by guarantee. The registered office is located at Unit 1, Bulrushes Farm, Coombe Hill Road, East Grinstead, West Sussex  RH19 4LZ.
The principal activity of the company continues to be that of promotion of educational course in the field of naturopathy and complimentary medicine.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A) of the Companies Act 2006.

 
2.2

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.3

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.4

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance sheet when the Company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Page 3


 
CNM THE COLLEGE OF NATUROPATHIC & COMPLEMENTARY MEDICINE LTD
 
(A company limited by guarantee)
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

3.


Debtors

2024
2023
£
£


Other debtors
-
166,848



4.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
14,902
88,070



5.


Creditors: Amounts falling due within one year

2024
2023
£
£

Other creditors
14,902
-

14,902
-




6.


Company status

The company is a private company limited by guarantee and consequently does not have share capital. Each of the members is liable to contribute an amount not exceeding £1 towards the assets of the company in the event of liquidation.

 
Page 4